Posted in:News PTAB Exercises its § 325(d) Discretion to Deny IPR of Piglet Vaccine Patent By Benjamin R. Holt November 5, 2018 Comments are off The August 2018 Update to the PTAB Trial Practice Guide added guidance regarding the Patent Trial and Appeal Board’s (“the Board”)... Read more Tagged with: Boehringer Ingelheim, Intervet International B.V., IPR, Merial, News, PTAB http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus